CinCor
CINCCinCor Pharma Price (CINC)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
35,419,099
(50.7602)%Balance Sheet Summary
| Total Assest | |
| Total Liabilities | |
| Total Equity | |
| Total Investments | |
| Total Liabilities And Total Equ... | |
| Total debt |
Balance Sheet
CinCor Pharma, Inc.Currency: USD
| YEAR | 2019 | 2020 | 2021 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash And Cash Equivalents | 11.48M | 26.08M | 136.61M | ||||||||||||||||
| Short Term Investments | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Net Receivables | 8.42k | 0.00 | 0.00 | ||||||||||||||||
| Inventory | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Other Current Assets | 0.00 | 0.00 | 4.50M | ||||||||||||||||
| Total Current Assets | 11.92M | 26.80M | 141.11M | ||||||||||||||||
| Non Current Assets | |||||||||||||||||||
| Property, Plant, and Equipment, Net | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Goodwill | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Intangible Assets | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Long Term Investments | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Tax Assets | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Other Assets | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Total Assets | 11.92M
+0% |
26.80M
+125% |
141.11M
+427% |
||||||||||||||||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Account Payables | 780.37k | 3.67M | 642.14k | ||||||||||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Tax Payables | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Deferred Revenue | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Other Current Liabilities | 942.77k | 3.23M | 15.91M | ||||||||||||||||
| Total Current Liabilities | 1.72M | 6.89M | 16.55M | ||||||||||||||||
| Non Current Liabilities | |||||||||||||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Deferred Tax Liabilities Non-Current | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Total Non-Current Liabilities | 15.18M | 47.17M | 188.27M | ||||||||||||||||
| Other Liabilities | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Capital Lease Obligations | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Total Liabilities | 16.91M
+0% |
54.06M
+220% |
204.82M
+279% |
||||||||||||||||
| Equity | |||||||||||||||||||
| Preferred Stock | 0.00 | 0.00 | 47.17M | ||||||||||||||||
| Common Stock | 43.00 | 43.00 | 26.00 | ||||||||||||||||
| Retained Earnings | -5,035,450.00 | -27,333,995.00 | -77,703,069.00 | ||||||||||||||||
| Accumulated Other Comprehensive Income Loss | 0.00 | 0.00 | -47,173,259.00 | ||||||||||||||||
| Other Total Stockholders Equity | 53.41k | 69.30k | 61.16M | ||||||||||||||||
| Total Stockholders Equity | -4,981,998.00 | -27,264,652.00 | -63,717,010.00 | ||||||||||||||||
| Minority Interest | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Total Equity | -4,981,998.00
+0% |
-27,264,652.00
+447% |
-63,717,010.00
+134% |
||||||||||||||||
| Total Liabilities And Total Equity | 11.92M
+0% |
26.80M
+125% |
141.11M
+427% |
||||||||||||||||
| Additional Metrics | |||||||||||||||||||
| Total Investments | 0.00
+0% |
0.00
+0% |
0.00
+0% |
||||||||||||||||
| Total Debt | 0.00
+0% |
0.00
+0% |
0.00
+0% |
||||||||||||||||
| Net Debt | -11,484,152.00 | -26,078,064.00 | -136,605,613.00 | ||||||||||||||||